Citations 1

Phase IIIb study of the bevacizumab biosimilar candidate BI 695502 plus mFOLFOX6 in metastatic colorectal cancer

Colorectal Cancer | November 9, 2022 | Volume: 11 | Issue: 1 | Pages: No page available

10.2217/crc-2022-0002